Paul M Meister is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 727,692 shares of AMRX, which is worth approximately $6.19 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 107,034 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 728K
0% 3M change
17.25% 12M change
Total Value Held $6.19 Million

PAUL M MEISTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Exercise of conversion of derivative security
-
107,034 Added 12.82%
727,692 Class A Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
112,179 Added 15.31%
620,658 Class A Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
52,677 Added 9.39%
508,479 Class A Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
-
74,230 Added 14.0%
455,802 Class A Common Stock

Also insider at

QTRX
Quanterix Corp Healthcare
APTV
Aptiv PLC Consumer Cyclical
DNAY
Codex DNA, Inc. Healthcare
PMM

Paul M Meister

Director
Billerica, MA

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX